Alum with Interleukin-12 Augments Immunity to a Melanoma Peptide Vaccine: Correlation with Time to Relapse in Patients with Resected High-Risk Disease - Concepedia

Concepedia

Publication | Closed Access

Alum with Interleukin-12 Augments Immunity to a Melanoma Peptide Vaccine: Correlation with Time to Relapse in Patients with Resected High-Risk Disease

81

Citations

34

References

2007

Year

Omid Hamid, Jolie C. Solomon, Ronald Scotland, Marile Garcia, Shirley Sian, Wei Ye, Susan L. Groshen, Jeffrey S. Weber

Clinical Cancer Research

Abstract

IL-12 with alum augmented an immune response to melanoma antigens compared with IL-12 with GM-CSF. Immune response was associated with time to relapse.

References

	Year	Citations

Page 1